Mylan CEO Bresch accepts “full responsibility” for EpiPen price hikes

Mylan (NSDQ:MYL) CEO Heather Bresch reportedly accepted “full responsibility” for the company’s EpiPen price hikes that sparked outrage over the past 2 months, but defended the company’s actions while blaming an opaque industry that she said was not built for consumer engagement. The CEO made her remarks at the Forbes Healthcare Summit in New York on Thursday.

“There are unintended consequences when the patient goes to the pharmacy counter and doesn’t know what the price will be,” Bresch said, according to Stat. “Transparency would improve this.”

Get the full story at our sister site, Drug Delivery Business News.

The post Mylan CEO Bresch accepts “full responsibility” for EpiPen price hikes appeared first on MassDevice.

from MassDevice http://ift.tt/2gICncT